Search Page

1

Cite

Share

Sleep disorders in advanced cancer patients: prevalence and factors associated.

Mercadante S, Girelli D, Casuccio A. Mercadante S, et al. Among authors: casuccio a. Support Care Cancer. 2004 May;12(5):355-9. doi: 10.1007/s00520-004-0623-4. Epub 2004 Apr 3. Support Care Cancer. 2004. PMID: 15064937

Cite

Share

2

Cite

Share

Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home.

Mercadante S, Casuccio A, Agnello A, Serretta R, Calderone L, Barresi L. Mercadante S, et al. Among authors: casuccio a. J Clin Oncol. 1998 Nov;16(11):3656-61. doi: 10.1200/JCO.1998.16.11.3656. J Clin Oncol. 1998. PMID: 9817288 Clinical Trial.

Cite

Share

3

Cite

Share

Ineffectiveness of dextromethorphan in cancer pain.

Mercadante S, Casuccio A, Genovese G. Mercadante S, et al. Among authors: casuccio a. J Pain Symptom Manage. 1998 Nov;16(5):317-22. J Pain Symptom Manage. 1998. PMID: 9846026 Free article. Clinical Trial.

Cite

Share

4

Cite

Share

Analgesic effects of nonsteroidal anti-inflammatory drugs in cancer pain due to somatic or visceral mechanisms.

Mercadante S, Casuccio A, Agnello A, Pumo S, Kargar J, Garofalo S. Mercadante S, et al. Among authors: casuccio a. J Pain Symptom Manage. 1999 May;17(5):351-6. doi: 10.1016/s0885-3924(98)00141-9. J Pain Symptom Manage. 1999. PMID: 10355213 Free article. Clinical Trial.

Cite

Share

5

Cite

Share

Rapid switching from morphine to methadone in cancer patients with poor response to morphine.

Mercadante S, Casuccio A, Calderone L. Mercadante S, et al. Among authors: casuccio a. J Clin Oncol. 1999 Oct;17(10):3307-12. doi: 10.1200/JCO.1999.17.10.3307. J Clin Oncol. 1999. PMID: 10506634

Cite

Share

6

Cite

Share

Methadone response in advanced cancer patients with pain followed at home.

Mercadante S, Casuccio A, Agnello A, Barresi L. Mercadante S, et al. Among authors: casuccio a. J Pain Symptom Manage. 1999 Sep;18(3):188-92. doi: 10.1016/s0885-3924(99)00048-2. J Pain Symptom Manage. 1999. PMID: 10517040 Free article. Clinical Trial.

Cite

Share

7

Cite

Share

Investigation of an opioid response categorization in advanced cancer patients.

Mercadante S, Fulfaro F, Casuccio A, Barresi L. Mercadante S, et al. Among authors: casuccio a. J Pain Symptom Manage. 1999 Nov;18(5):347-52. doi: 10.1016/s0885-3924(99)00099-8. J Pain Symptom Manage. 1999. PMID: 10584458 Free article.

Cite

Share

8

Cite

Share

Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial.

Ripamonti C, Mercadante S, Groff L, Zecca E, De Conno F, Casuccio A. Ripamonti C, et al. Among authors: casuccio a. J Pain Symptom Manage. 2000 Jan;19(1):23-34. doi: 10.1016/s0885-3924(99)00147-5. J Pain Symptom Manage. 2000. PMID: 10687323 Free article. Clinical Trial.

Cite

Share

9

Cite

Share

Factors influencing the opioid response in advanced cancer patients with pain followed at home: the effects of age and gender.

Mercadante S, Casuccio A, Pumo S, Fulfaro F. Mercadante S, et al. Among authors: casuccio a. Support Care Cancer. 2000 Mar;8(2):123-30. doi: 10.1007/s005200050026. Support Care Cancer. 2000. PMID: 10739359

Cite

Share

10

Cite

Share

Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction.

Mercadante S, Ripamonti C, Casuccio A, Zecca E, Groff L. Mercadante S, et al. Among authors: casuccio a. Support Care Cancer. 2000 May;8(3):188-91. doi: 10.1007/s005200050283. Support Care Cancer. 2000. PMID: 10789958 Clinical Trial.

Cite

Share